Sign In
Buy HROW
$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders
11:31am, Friday, 13'th Mar 2020
The company is not expecting disruptions in its business or supply chain as a result of the recent COVID-19 virus concerns in the US and around the world. The company has double checked inventories a
Every London coronavirus case mapped showing where the threat is highest
06:52am, Friday, 13'th Mar 2020
The number of diagnoses in London has passed 100
Should You Be Impressed By Harrow Health, Inc.'s (NASDAQ:HROW) ROE?
01:29pm, Thursday, 12'th Mar 2020
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
ImprimisRx® Announces Supply Agreement with EyeCare Services Partners
11:30am, Thursday, 12'th Mar 2020
ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (HROW), announced that it has a
ImprimisRx® Announces Supply Agreement with iOR Partners
11:30am, Monday, 09'th Mar 2020
ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (HROW), announced that it has a
Every London borough where a coronavirus case has been confirmed
04:56pm, Saturday, 07'th Mar 2020
Check if your borough has had any confirmed cases
Air Ambulance paramedics called to more stabbings than any other emergency
07:12pm, Tuesday, 03'rd Mar 2020
The Air Ambulance has released its annual statistics and a lot has changed
ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA)
12:30pm, Tuesday, 03'rd Mar 2020
ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (HROW), announced that it has a
Harrow Health to Announce Fourth Quarter 2019 Financial Results on March 13, 2020
12:30pm, Thursday, 27'th Feb 2020
Harrow Health, Inc. (HROW) today announced that before the open of trading on Friday, March 13, 2020, it will release fourth quarter 2019 financial results and host a conference call at 8:30 a.m. East
Implied Volatility Surging for Harrow Health (HROW) Stock Options
02:24pm, Monday, 03'rd Feb 2020
Investors need to pay close attention to Harrow Health (HROW) stock based on the movements in the options market lately.
Why Harrow Health, Inc.'s (NASDAQ:HROW) CEO Pay Matters To You
04:34pm, Monday, 27'th Jan 2020
Mark Baum has been the CEO of Harrow Health, Inc. (NASDAQ:HROW) since 2012. This report will, first, examine the CEO...
Is Harrow Health, Inc. (HROW) A Good Stock To Buy?
12:35pm, Monday, 16'th Dec 2019
Is Harrow Health, Inc. (NASDAQ:HROW) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been se
The Harrow Health (NASDAQ:HROW) Share Price Is Up 256% And Shareholders Are Boasting About It
12:40pm, Thursday, 12'th Dec 2019
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
Inventor Of "LessDrops," Surgical Eyedrop, Wins Return Of Patent From Harrow Health
12:40am, Wednesday, 11'th Dec 2019
Novel Drug Solutions, LLC and Eye Care Northwest, PA, announce the return of their unrestricted patent rights to several awarded and pending USA and international patents previously controlled by Harr
ImprimisRx’s FDA-Registered Outsourcing Facility Issued California License
12:30pm, Tuesday, 10'th Dec 2019
ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow Health, Inc. (HROW), announced that on December
